Image 1
Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 24979-035
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 24979-035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
15 (Image 4)
Image 5
Image 6
Image 7
Image 8
Each extended-release capsule contains 15 g of Gyelobenzaprine hydrochloride USP (Cyclobenzaprine hydrochloride). These capsules should be stored at 20° to 25°C (68° to 77°F) in a tightly sealed container. The medication should be kept away from children. The manufacturer is Pramacesials and it is manufactured in Taiwan.*
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
